< Back

October, 2017

Evolving Market Dynamics Will Continue to Influence and Limit Access to Branded Diabetes Drugs by 2019

Brand Access Marketplace Dynamics    |    Research Released October 2017

Evolving Market Dynamics Will Continue to Influence and Limit Access to Branded Diabetes Drugs by 2019

The availability of new brands and biosimilars, along with potential entrance of multisource generics, will compel stakeholders to intensify management tactics to further narrow access to preferred branded diabetes drugs.

Biopharmaceutical companies that support stakeholder objectives of achieving high-quality, cost-effective long-term care for diabetes patients will likely achieve or sustain optimal access for their brands.

Key trends driving stakeholder strategies to influence access to diabetes drugs

download research slide

 

These and other findings can be found in Health Strategies Group’s recently released research Diabetes Market Access Stakeholder Drug Management Outlook 2019.

Key topics covered in this research:

  • Evolution of diabetes market
  • Future stakeholder management tactics for diabetes products: payers, health systems, medical groups.
  • Brand access predictions based on detailed scenarios
  • Evolving stakeholder contracting activities and influence on brand access

Download Research Agenda

 

Visit our Brand Access Marketplace Dynamics webpage to learn more about this research.

Disclaimer

 

Please complete the form to have this document sent to your email.

 

Please complete the form to have this document sent to your email.